Assistant Professor, Medicine, UCSF School of Medicine
Internal Medicine
Dr. Amy Y. Lin, MD
|
|
Give Review
practices Internal Medicine. She went to medical school at University of Chicago Pritzker School of Medicine. University of Chicago Pritzker School of Medicine is ranked 10/19 in Research/PrimaryCare. She received 1 awards: "CMS Meaningful Use Stage 1 Certification". Amy Y. Lin, MD is a published doctor as well. She has 28 publications published. The latest was: Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Can... is registered with Medicare and accepts Medicare payments.
Publications
- Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Can...
- Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulatin...
- Intestinal tumor suppression in Apc(Min/+) mice by prostaglandin D2 receptor PTGDR.
- A phase II study of insulin-like growth factor receptor inhibition with nordihydroguaiaretic acid in men with non-metastatic hormone-sensitive prostate ...
- Hematopoietic prostaglandin D synthase (HPGDS): A high stability, Val187Ile isoenzyme common among African Americans and its relationship to risk for colorectal cancer.
- A phase 1 study of everolimus and sorafenib for metastatic clear Cell renal Cell carcinoma.
- Tumor fistulization associated with targeted therapy: computed tomographic findings and clinical consequences.
- Effect of the somatostatin analog octreotide acetate on circulating insulin-like growth factor-1 and related peptides in patients with non-metastatic castration-resist...
- Asymptomatic maternal combined homocystinuria and methylmalonic aciduria (cblC) detected through low carnitine levels on newborn screening.
- Potentiating endogenous antitumor immunity to prostate cancer through combination immunotherapy with CTLA4 blockade and GM-CSF.
- Prostate cancer update: 2007.
- Management of hormone refractory prostate cancer.
- A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer.
- Prostate cancer update: 2006.
- Immunotherapy for prostate cancer using prostatic acid phosphatase loaded antigen presenting Cells.
- Angiogenesis inhibition plus chemotherapy for metastatic hormone refractory prostate cancer: history and rationale.
- Targeting RNA polymerase I with an oral small molecule CX-5461 inhibits ribosomal RNA synthesis and solid tumor growth.
- Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis.
- Toxicology in the fast lane: application of high-throughput bioassays to detect modulation of key enzymes and receptors.
- Protein kinase C-associated kinase (PKK) mediates Bcl10-independent NF-kappa B activation induced by phorbol ester.
- Proliferating macrophages associated with high grade, hormone receptor negative breast cancer and poor clinical outcome.
- The role of trastuzumab in early stage breast cancer: current data and treatment recommendations.
- Phase II study of ketoconazole plus granulocyte-macrophage colony-stimulating factor for prostate cancer: effect of extent of Disease on outcome.
- A pilot dose-escalation study of the effects of nordihydroguareacetic acid on hormone and prostate specific antigen levels in patients with relapsed prostate cancer.
- Clinical trials in patients with biochemically relapsed prostate cancer.
- A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapy.
- Intermittent chemotherapy for metastatic hormone refractory prostate cancer.
Schools
U Of Chgo Div Of Bio Sci Pritzker Sch Of Med
Conditions Treated
- Anemia
- Lymphoma
- Myeloma
- Non-Hodgkin's Lymphoma
- View All
Doctors Specialties
- Hematology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
UCSF -
New York Presbyterian Hospital -
University of Chicago Pritzker School of Medicine
Hospital
-
San Francisco VA Medical Center -
UCSF Medical Center
Helpful Reviews
Similar Doctors
|
|
Dr. Thomas T. Reid, MD |
|
|
Dr. Chitra Chandran, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Sheena X. Kong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph C. Chiovaro, MD |
|
|
Dr. Jonathan P. Alexander, MD |
|
|
Dr. Aravind Mani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kathleen M. Grant, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hope S. Rugo, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Kerstin Morehead, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Cohen, MD |
|
|
Dr. Patricia A. Cornett, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gallia G. Levy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David Y. Lou, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marc A. Shuman, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Melisa L. Wong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Xiao X. Wei |